These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 1704690)

  • 1. Multiple-dose evaluation of intravenous hydromorphone pharmacokinetics in normal human subjects.
    Hill HF; Coda BA; Tanaka A; Schaffer R
    Anesth Analg; 1991 Mar; 72(3):330-6. PubMed ID: 1704690
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetics of hydromorphone hydrochloride after intravenous and intramuscular administration of a single dose to American kestrels (Falco sparverius).
    Guzman DS; KuKanich B; Drazenovich TL; Olsen GH; Paul-Murphy JR
    Am J Vet Res; 2014 Jun; 75(6):527-31. PubMed ID: 24866507
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetics and physiological effects of intravenous hydromorphone in conscious dogs.
    Guedes AG; Papich MG; Rude EP; Rider MA
    J Vet Pharmacol Ther; 2008 Aug; 31(4):334-43. PubMed ID: 18638294
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Determination of hydromorphone in human plasma by a sensitive RP-HPLC-ESI-MS method and its application to a clinical pharmacokinetic study in postoperative patients after low dose intravenous administration with infusion pump.
    Sun L; Pan Y; Ding L; Luo X; Yan Z; Liu C; Qian Y; Chu Y
    J Pharm Biomed Anal; 2012 Mar; 61():15-21. PubMed ID: 22169470
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics of hydromorphone after intravenous and intramuscular administration in male rhesus macaques (Macaca mulatta).
    Kelly KR; Pypendop BH; Christe KL
    J Am Assoc Lab Anim Sci; 2014 Sep; 53(5):512-6. PubMed ID: 25255074
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetics and bioavailability of hydromorphone: effect of various routes of administration.
    Chang SF; Moore L; Chien YW
    Pharm Res; 1988 Nov; 5(11):718-21. PubMed ID: 2470073
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetic and pharmacodynamic evaluation of intravenous hydromorphone in cats.
    Wegner K; Robertson SA; Kollias-Baker C; Sams RA; Muir WW
    J Vet Pharmacol Ther; 2004 Oct; 27(5):329-36. PubMed ID: 15500571
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The pharmacokinetics and pharmacodynamics of intravenous hydromorphone in horses.
    Reed R; Barletta M; Mitchell K; Hanafi A; Bullington A; Knych H; Quandt J; Ryan C; Giguère S
    Vet Anaesth Analg; 2019 May; 46(3):395-404. PubMed ID: 30930095
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetics and bioavailability of single-dose intranasal hydromorphone hydrochloride in healthy volunteers.
    Coda BA; Rudy AC; Archer SM; Wermeling DP
    Anesth Analg; 2003 Jul; 97(1):117-23, table of contents. PubMed ID: 12818953
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Population pharmacokinetic modeling of hydromorphone in cardiac surgery patients during postoperative pain therapy.
    Jeleazcov C; Saari TI; Ihmsen H; Mell J; Fröhlich K; Krajinovic L; Fechner J; Schüttler J
    Anesthesiology; 2014 Feb; 120(2):378-91. PubMed ID: 23958818
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics of hydromorphone hydrochloride after intramuscular and intravenous administration of a single dose to orange-winged Amazon parrots (
    Sanchez-Migallon Guzman D; Knych H; Douglas J; Paul-Murphy JR
    Am J Vet Res; 2020 Nov; 81(11):894-898. PubMed ID: 33107746
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetics of a controlled-release liposome-encapsulated hydromorphone administered to healthy dogs.
    Smith LJ; KuKanich B; Hogan BK; Brown C; Heath TD; Krugner-Higby LA
    J Vet Pharmacol Ther; 2008 Oct; 31(5):415-22. PubMed ID: 19000260
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetics of hydrorphone hydrochloride after intravenous and subcutaneous administration in ferrets (Mustela putorius furo).
    Hech B; Knych H; Desprez I; Weiner D; Ambros B
    Vet Anaesth Analg; 2024; 51(2):152-159. PubMed ID: 38158281
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetics of hydromorphone after intravenous, peroral and rectal administration to human subjects.
    Parab PV; Ritschel WA; Coyle DE; Gregg RV; Denson DD
    Biopharm Drug Dispos; 1988; 9(2):187-99. PubMed ID: 2453226
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High bioavailability, short half-life, and metabolism into hydromorphone-3-glucuronide following single intramuscular and intravenous administration of hydromorphone hydrochloride to great horned owls (Bubo virginianus).
    Sosa-Higareda M; Sanchez-Migallon Guzman D; Knych HK; Hawkins MG
    Am J Vet Res; 2023 May; 84(5):. PubMed ID: 36881501
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of a method for the determination of hydromorphone in plasma by LC-MS.
    Cox S; Bergman J; Hawkins S; Sladky K
    Biomed Chromatogr; 2018 Dec; 32(12):e4357. PubMed ID: 30074252
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A multiple-dose phase I study of intranasal hydromorphone hydrochloride in healthy volunteers.
    Rudy AC; Coda BA; Archer SM; Wermeling DP
    Anesth Analg; 2004 Nov; 99(5):1379-1386. PubMed ID: 15502034
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetics of dexloxiglumide after administration of single and repeat oral escalating doses in healthy young males.
    Persiani S; D'Amato M; Makovec F; Tavares IA; Bishai PM; Rovati LC
    Int J Clin Pharmacol Ther; 2002 May; 40(5):198-206. PubMed ID: 12051571
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hydromorphone population pharmacokinetics in pediatric surgical patients.
    Balyan R; Dong M; Pilipenko V; Geisler K; Vinks AA; Chidambaran V
    Paediatr Anaesth; 2020 Oct; 30(10):1091-1101. PubMed ID: 32702184
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Absolute bioavailability of hydromorphone after peroral and rectal administration in humans: saliva/plasma ratio and clinical effects.
    Ritschel WA; Parab PV; Denson DD; Coyle DE; Gregg RV
    J Clin Pharmacol; 1987 Sep; 27(9):647-53. PubMed ID: 2445789
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.